Abstract
A total of 20 examples of 2-[(1H-indol-1-yl)(aryl)methyl]-1,3-diphenylpropane-1,3-diones were efficiently synthesized by the aza-Michael addition at the N1 position of indoles with 2-aroyl-1,3-diarylenones at room temperature in the presence of potassium hydroxide. The salient features of this protocol are no transition-metal catalysts, mild conditions, high chemoselectivity, high atom economy, high yields, and a simple work-up procedure.
Introduction
The aza-Michael reaction is one of the most popular methods for carbon–nitrogen bond formation and the shortest way to prepare β-aminocarbonyl compounds, which are widely used for the synthesis of naturally occurring nitrogen-containing heterocyclic scaffolds and pharmaceuticals.1–5 A few NH compounds including aromatic amines, 6 aliphatic amines,7–9 α-amino esters, 10 benzotriazoles,11,12 pyrazole,13,14 indazole, 15 piperazine, 16 and urazole 17 as Michael donors, and alkenyl sulfones, 6 nitroolefins,18,19 alkenyl benzimidazoles, 20 and α,β-unsaturated ketones,21–24 acids, 25 esters, 26 amides, 27 and imides 28 as Michael acceptors were reported. However, some drawbacks still remain for these existing methods, for example, the use of transition-metal catalysts and low yields.
Indole, as a Michael donor, can be used to easily introduce a heterocycle to functionalized molecules. Meanwhile, enones, as important Michael acceptors, can participate in addition reactions. However, the reported reactions of indole with enones generally take place at the C3 or C2 positions.29–37 There is scant literature on the aza-Michael addition reactions at the N1 position.38,39
2-Aroyl-1,3-diarylenones have many important applications in organic synthesis.40–43 However, to the best our knowledge, there are no reports on their use in aza-Michael addition reactions.
In this work, we report high-yielding chemoselective aza-Michael additions at the N1 position of (un)substituted indoles with 2-aroyl-1,3-diarylenones under transition-metal-free and mild conditions.
Results and discussion
Initially the reaction of 2-benzylidene-1,3-diphenylpropan-1,3-dione (

Aza-Michael addition of indoles to 2-aroyl-1,3-diarylenones.
Effect of the reaction conditions (base, solvent) on the yield of
Reaction conditions:
Isolated yield.
Base (0.4 mmol).
With optimized reaction conditions in hand, the scope of aza-Michael addition of (un)substituted indoles with 2-aroyl-1,3-diarylenones in MeCN at room temperature using 2 equiv. of KOH as the base was examined. The results are summarized in Table 2. It was found that for the typical situation (R = H), a wide range of substituents on the Ar group of compounds
Synthesis of 2-[(1H-indol-1-yl)(aryl)methyl]-1,3-diphenylpropane-1,3-diones
Reaction conditions: 2-aroyl-1,3-diarylenone
Isolated yield.
The synthesized products can be found applications in the important synthesis. For example, the reaction of product

Synthesis of 1-[(3,5-diphenyl-1H-pyrazol-4-yl)(phenyl)methyl]-1H-indole (
In conclusion, an efficient method for the aza-Michael addition at the N1 position of indoles with 2-aroyl-1,3-diphenylenones has been developed. A series of 2-[(1H-indol-1-yl)(aryl)methyl]-1,3-diarylpropane-1,3-diones has been synthesized in high yields. The protocol tolerates a wide range of substrates, does not require transition-metal catalysts, and utilizes mild conditions. The products are obtained with high chemoselectivity, high yields, and high atom economy. This method provides an alternative for the straightforward preparation of N-heterocycle-functionalized 1,3-diones.
Experiment
1H NMR and 13C NMR spectra were obtained with a Mercury-600BB instrument using CDCl3 or DMSO-d6 as solvents and Me4Si as the internal standard. High-resolution mass spectra (HRMS) (ESI) were obtained with Bruker Daltonics APEX II 47e and Orbitrap Elite mass spectrometers. Melting points were observed in an electrothermal melting point apparatus (X-5, Beijing Tech Instrument Co. Ltd, China). Unless otherwise noted, the solvents and reagents were reagent grade and were used without any further purification. Column chromatographic separations were carried out on a flash chromatographic system using silica gel (200–300 mesh), and petroleum ether (60–90 °C) and ethyl acetate as eluent. For thin layer chromatography (TLC), silica gel plates precoated with GF-254 were used. The 2-aroyl-1,3-diarylenones were prepared according to the literature procedure. 44
Preparation of 2-[(1H-indol-1-yl)(aryl)methyl]-1,3-diphenylpropan-1,3-diones (2a –t )
A mixture of 2-aroyl-1,3-diarylenone (0.2 mmol), indole (0.2 mmol) and potassium hydroxide (0.4 mmol) in acetonitrile (2 mL) were stirred at room temperature for 4 h. The reaction progress was monitored by TLC. After completion of the reaction, the mixture was extracted with ethyl acetate (3 × 10 mL). The combined organic layer was washed with saturated brine (3 × 10 mL), dried over anhydrous sodium sulfate, and concentrated under reduced pressure. The residue was isolated by column chromatography using petroleum ether and ethyl acetate (5:1, v/v) as eluent to give the pure product.
2-[(1H-Indol-1-yl)(phenyl)methyl]-1,3-diphenylpropane-1,3-dione (2a )
White solid (80 mg, 95%); m.p. 202–205 °C; 1H NMR (600 MHz, CDCl3): δ 7.91 (d, J = 8.2 Hz, 2H), 7.70 (d, J = 8.3 Hz, 2H), 7.52 (t, J = 7.5 Hz, 1H), 7.42 (d, J = 8.3 Hz, 1H), 7.40 (d, J = 4.0 Hz, 4H), 7.28 (d, J = 7.4 Hz, 2H), 7.24–7.10 (m, 7H), 6.98 (t, J = 7.4 Hz, 1H), 6.80 (d, J = 11.1 Hz, 1H), 6.62 (d, J = 11.1 Hz, 1H), 6.32 (d, J = 3.2 Hz, 1H); 13C NMR (150 MHz, CDCl3): δ 192.42, 192.23, 138.39, 136.26, 136.08, 135.86, 133.73, 133.44, 128.84, 128.76, 128.61, 128.40, 128.36, 128.26, 128.08, 127.13, 125.23, 121.88, 120.62, 119.64, 110.26, 102.91, 60.48, 60.08; HRMS (ESI): m/z [M+H]+ calcd for C30H24NO2: 430.1802; found: 430.1803.
2-[(1H-Indol-1-yl)(o-tolyl)methyl]-1,3-diphenylpropane-1,3-dione (2b )
White solid (74 mg, 86%); m.p. 128–131 °C; 1H NMR (600 MHz, CDCl3): δ 7.90 (d, J = 7.4 Hz, 2H), 7.58 (d, J = 7.2 Hz, 2H), 7.52 (dd, J = 7.9, 3.9 Hz, 2H), 7.46 (d, J = 8.7 Hz, 1H), 7.40–7.33 (m, 3H), 7.28 (d, J = 8.0 Hz, 1H), 7.17–7.10 (m, 6H), 7.00 (d, J = 3.3 Hz, 1H), 6.96–6.92 (m, 2H), 6.74 (d, J = 11.0 Hz, 1H), 6.22 (d, J = 3.2 Hz, 1H), 2.23 (s, 3H); 13C NMR (150 MHz, CDCl3): δ 193.96, 192.03, 137.98, 136.52, 136.11, 135.93, 135.64, 133.63, 133.37, 131.63, 128.89, 128.32, 128.17, 128.13, 128.02, 127.99, 125.89, 125.48, 125.28, 121.84, 120.48, 119.46, 110.17, 103.15, 58.88, 56.76, 19.68; HRMS (ESI): m/z [M+H]+ calcd for C31H26NO2: 444.1958; found: 444.1956.
2-[(1H-Indol-1-yl)(m-tolyl)methyl]-1,3-diphenylpropane-1,3-dione (2c )
White solid (66 mg, 76%); m.p. 151–154 °C; 1H NMR (600 MHz, CDCl3): δ 7.93 (d, J = 7.1 Hz, 2H), 7.72 (d, J = 7.0 Hz, 2H), 7.54–7.48 (m, 2H), 7.40 (q, J = 8.2 Hz, 4H), 7.25–7.20 (m, 3H), 7.17–7.11 (m, 3H), 7.09 (t, J = 7.5 Hz, 1H), 7.02–6.96 (m, 2H), 6.79 (d, J = 11.1 Hz, 1H), 6.66 (d, J = 11.1 Hz, 1H), 6.34 (d, J = 3.1 Hz, 1H), 2.19 (s, 3H); 13C NMR (150 MHz, CDCl3): δ 192.60, 192.33, 138.52, 138.27, 136.35, 136.12, 135.91, 133.70, 133.45, 128.93, 128.83, 128.60, 128.59, 128.42, 128.36, 128.27, 125.22, 123.93, 121.88, 120.61, 119.63, 110.30, 102.90, 60.39, 60.08, 21.40; HRMS (ESI): m/z [M+H]+ calcd for C31H26NO2: 444.1958; found: 444.1959.
2-[(1H-Indol-1-yl)(p-tolyl)methyl]-1,3-diphenylpropane-1,3-dione (2d )
White solid (78 mg, 90%); m.p. 201–205 °C; 1H NMR (600 MHz, CDCl3): δ 7.93 (d, J = 7.5 Hz, 2H), 7.70 (d, J = 7.5 Hz, 2H), 7.53 (t, J = 7.3 Hz, 1H), 7.45 (d, J = 8.3 Hz, 1H), 7.42–7.37 (m, 4H), 7.24–7.16 (m, 5H), 7.13 (t, J = 7.7 Hz, 1H), 6.99 (dd, J = 19.9, 7.5 Hz, 3H), 6.79 (d, J = 11.1 Hz, 1H), 6.63 (d, J = 11.1 Hz, 1H), 6.31 (d, J = 3.2 Hz, 1H), 2.21 (s, 3H); 13C NMR (150 MHz, CDCl3): δ 192.68, 192.26, 137.81, 136.33, 136.05, 135.90, 135.44, 133.68, 133.40, 129.45, 128.84, 128.63, 128.37, 128.26, 127.04, 125.31, 121.82, 120.59, 119.58, 110.30, 102.85, 60.52, 59.88, 20.97; HRMS (ESI): m/z [M+H]+ calcd for C31H26NO2: 444.1958; found: 444.1957.
2-[(1H-Indol-1-yl)(2-methoxyphenyl)methyl]-1,3-diphenylpropane-1,3-dione (2e )
White solid (80 mg, 88%); m.p. 103–106 °C; 1H NMR (600 MHz, CDCl3): δ 7.90 (d, J = 7.6 Hz, 2H), 7.71 (d, J = 7.1 Hz, 2H), 7.55 (d, J = 8.3 Hz, 1H), 7.49 (t, J = 7.4 Hz, 1H), 7.42–7.34 (m, 5H), 7.28 (s, 1H), 7.23 (t, J = 7.9 Hz, 2H), 7.15–7.10 (m, 2H), 7.05 (d, J = 11.2 Hz, 1H), 6.95 (t, J = 7.5 Hz, 1H), 6.85–6.81 (m, 2H), 6.72 (d, J = 8.2 Hz, 1H), 6.29 (dd, J = 3.3, 0.8 Hz, 1H), 3.67 (s, 3H); 13C NMR (150 MHz, CDCl3): δ 193.35, 192.29, 157.06, 136.37, 136.23, 136.20, 133.41, 133.28, 129.40, 128.65, 128.50, 128.44, 128.34, 128.23, 128.03, 126.46, 125.57, 121.59, 120.62, 120.34, 119.28, 111.33, 110.34, 102.40, 59.96, 55.69, 55.35; HRMS (ESI): m/z [M+H]+ calcd for C31H26NO3: 460.1907; found: 460.1905.
2-[(1H-Indol-1-yl)(4-methoxyphenyl)methyl]-1,3-diphenylpropane-1,3-dione (2f )
White solid (82 mg, 90%); m.p. 180–183 °C; 1H NMR (600 MHz, CDCl3): δ 7.92 (d, J = 7.1 Hz, 2H), 7.70 (d, J = 7.5 Hz, 2H), 7.53 (t, J = 7.4 Hz, 1H), 7.44–7.37 (m, 5H), 7.22 (t, J = 8.4 Hz, 4H), 7.16 (d, J = 3.3 Hz, 1H), 7.12 (t, J = 7.7 Hz, 1H), 6.97 (t, J = 7.4 Hz, 1H), 6.76 (d, J = 11.1 Hz, 1H), 6.71 (d, J = 8.7 Hz, 2H), 6.60 (d, J = 11.1 Hz, 1H), 6.31 (d, J = 3.1 Hz, 1H), 3.68 (s, 3H); 13C NMR (150 MHz, CDCl3): δ 192.53, 192.29, 159.17, 136.34, 136.01, 135.90, 133.70, 133.40, 130.55, 128.85, 128.62, 128.38, 128.33, 128.25, 125.18, 121.82, 120.60, 119.58, 114.13, 110.31, 102.81, 60.75, 59.60, 55.16; HRMS (ESI): m/z [M+H]+ calcd for C31H26NO3: 460.1907; found: 460.1908.
2-[(1H-Indol-1-yl)(4-(trifluoromethyl)phenyl)methyl]-1,3-diphenylpropane-1,3-dione (2g )
White solid (84 mg, 86%); m.p. 184–186 °C; 1H NMR (600 MHz, CDCl3): δ 7.92 (d, J = 7.2 Hz, 2H), 7.71 (d, J = 7.2 Hz, 2H), 7.55 (t, J = 7.4 Hz, 1H), 7.46 (d, J = 8.2 Hz, 2H), 7.40 (q, J = 8.6, 7.5 Hz, 7H), 7.24 (s, 2H), 7.16 (d, J = 3.4 Hz, 2H), 7.01 (t, J = 7.4 Hz, 1H), 6.85 (d, J = 11.0 Hz, 1H), 6.62 (d, J = 11.0 Hz, 1H), 6.36 (d, J = 3.2 Hz, 1H); 13C NMR (150 MHz, CDCl3): δ 192.10, 192.09, 142.44, 135.96, 135.66, 134.07, 133.65, 130.40, 130.18, 128.99, 128.62, 128.48, 128.28, 127.56, 125.79 (q, J = 3.9 Hz), 125.09, 124.60, 122.79, 122.18, 120.85, 119.96, 110.02, 103.49, 60.20, 59.67; HRMS (ESI): m/z [M+H]+ calcd for C31H23F3NO2: 498.1675; found: 498.1675.
2-[(3-Fluorophenyl)(1H-indol-1-yl)methyl]-1,3-diphenylpropane-1,3-dione (2h )
White solid (77 mg, 82%); m.p. 192–195 °C; 1H NMR (600 MHz, CDCl3): δ 7.92 (d, J = 7.1 Hz, 2H), 7.70 (d, J = 7.1 Hz, 2H), 7.54 (t, J = 7.4 Hz, 1H), 7.40 (t, J = 7.2 Hz, 5H), 7.25–7.22 (m, 2H), 7.18–7.12 (m, 3H), 7.07 (d, J = 7.4 Hz, 1H), 7.02–6.96 (m, 2H), 6.85 (t, J = 8.4 Hz, 1H), 6.78 (d, J = 11.1 Hz, 1H), 6.58 (d, J = 11.0 Hz, 1H), 6.35 (d, J = 3.3 Hz, 1H); 13C NMR (150 MHz, CDCl3): δ 192.10, 192.02, 162.80 (d, J = 246.0 Hz), 140.97 (d, J = 6.8 Hz), 136.05 (d, J = 6.1 Hz), 135.73, 133.92, 133.55, 130.39, 130.33, 128.93, 128.61, 128.47, 128.42, 128.27, 125.01, 122.86 (d, J = 2.9 Hz), 122.07, 120.75, 119.85, 115.13 (d, J = 21.1 Hz), 114.29 (d, J = 22.4 Hz), 110.11, 103.26, 60.36, 59.58; HRMS (ESI): m/z [M+H]+ calcd for C30H23FNO2: 448.1707; found: 448.1707.
2-[(4-Fluorophenyl)(1H-indol-1-yl)methyl]-1,3-diphenylpropane-1,3-dione (2i )
White solid (78 mg, 88%); m.p. 183–185 °C; 1H NMR (600 MHz, CDCl3): δ 7.93 (d, J = 7.1 Hz, 2H), 7.73 (d, J = 7.7 Hz, 2H), 7.54 (t, J = 7.4 Hz, 1H), 7.41 (q, J = 8.3, 7.8 Hz, 5H), 7.30–7.26 (m, 2H), 7.25–7.22 (t, J = 7.9 Hz, 2H), 7.19 (d, J = 3.2 Hz, 1H), 7.16–7.13 (m, 1H), 7.01 (t, J = 7.4 Hz, 1H), 6.88 (t, J = 8.6 Hz, 2H), 6.81 (d, J = 11.1 Hz, 1H), 6.62 (d, J = 11.1 Hz, 1H), 6.36 (d, J = 3.3 Hz, 1H); 13C NMR (150 MHz, CDCl3): δ 192.25, 192.20, 162.21 (d, J = 246.1 Hz), 136.15, 136.02, 135.79, 134.37 (d, J = 3.1 Hz), 133.94, 133.58, 128.95, 128.90 (d, J = 8.1 Hz), 128.63, 128.49, 128.45, 128.29, 125.01, 122.03, 120.76, 119.82, 115.73 (d, J = 21.7 Hz), 110.19, 103.17, 60.61, 59.48; HRMS (ESI): m/z [M+H]+ calcd for C30H23FNO2: 448.1707; found: 448.1709.
2-[(2-Chlorophenyl)(1H-indol-1-yl)methyl]-1,3-diphenylpropane-1,3-dione (2j )
White solid (75 mg, 82%); m.p. 179–182 °C; 1H NMR (600 MHz, CDCl3): δ 7.90 (dd, J = 8.4, 1.3 Hz, 2H), 7.67–7.63 (m, 2H), 7.55–7.49 (m, 3H), 7.38 (dd, J = 7.2, 1.3 Hz, 3H), 7.33–7.29 (m, 2H), 7.23–7.10 (m, 7H), 6.95 (t, J = 7.4 Hz, 1H), 6.68 (d, J = 11.0 Hz, 1H), 6.29 (d, J = 3.3 Hz, 1H); 13C NMR (150 MHz, CDCl3): δ 193.08, 191.92, 136.09, 135.92, 135.78, 135.68, 134.97, 133.75, 133.49, 130.74, 129.39, 128.87, 128.45, 128.31, 128.13, 128.07, 127.60, 126.82, 125.25, 121.89, 120.49, 119.59, 110.47, 103.25, 59.54, 56.82; HRMS (ESI): m/z [M+H]+ calcd for C30H23ClNO2: 464.1412; found: 464.1410.
2-[(3-Chlorophenyl)(1H-indol-1-yl)methyl]-1,3-diphenylpropane-1,3-dione (2k )
White solid (89 mg, 97%); m.p. 207–209 °C; 1H NMR (600 MHz, CDCl3): δ 7.92 (d, J = 7.5 Hz, 2H), 7.71 (d, J = 7.3 Hz, 2H), 7.54 (t, J = 7.4 Hz, 1H), 7.41 (t, J = 7.6 Hz, 5H), 7.28 (s, 1H), 7.25 (s, 1H), 7.24 (s, 1H), 7.19 (d, J = 6.7 Hz, 1H), 7.17 (d, J = 3.3 Hz, 1H), 7.15–7.10 (m, 3H), 7.03–6.99 (m, 1H), 6.76 (d, J = 11.1 Hz, 1H), 6.58 (d, J = 11.1 Hz, 1H), 6.36 (d, J = 3.3 Hz, 1H); 13C NMR (150 MHz, CDCl3): δ 192.12, 192.05, 140.45, 136.05, 136.03, 135.71, 134.73, 133.95, 133.59, 130.03, 128.94, 128.62, 128.49, 128.40, 128.37, 128.28, 127.43, 125.38, 124.92, 122.12, 120.77, 119.88, 110.09, 103.36, 60.27, 59.56; HRMS (ESI): m/z [M+H]+ calcd for C30H23ClNO2: 464.1412; found: 464.1413.
2-[(4-Chlorophenyl)(1H-indol-1-yl)methyl]-1,3-diphenylpropane-1,3-dione (2l )
White solid (79 mg, 86%); m.p. 189–192 °C; 1H NMR (600 MHz, CDCl3): δ 7.91 (d, J = 7.1 Hz, 2H), 7.69 (d, J = 7.2 Hz, 2H), 7.55 (t, J = 7.4 Hz, 1H), 7.43–7.36 (m, 5H), 7.24–7.20 (m, 4H), 7.16 (d, J = 8.5 Hz, 2H), 7.15–7.11 (m, 2H), 6.99 (t, J = 7.4 Hz, 1H), 6.77 (d, J = 11.1 Hz, 1H), 6.57 (d, J = 11.1 Hz, 1H), 6.33 (d, J = 3.4 Hz, 1H); 13C NMR (150 MHz, CDCl3): δ 192.17, 192.10, 137.01, 136.07, 135.96, 135.72, 133.96, 133.56, 128.96, 128.63, 128.62, 128.50, 128.46, 128.43, 128.26, 125.06, 122.05, 120.76, 119.83, 110.12, 103.24, 60.42, 59.50; HRMS (ESI): m/z [M+H]+ calcd for C30H23ClNO2: 464.1412; found: 464.1414.
2-[(2-Bromophenyl)(1H-indol-1-yl)methyl]-1,3-diphenylpropane-1,3-dione (2m )
White solid (71 mg, 70%); m.p. 204–206°C; 1H NMR (600 MHz, CDCl3): δ 7.89 (d, J = 8.1 Hz, 2H), 7.63 (d, J = 7.7 Hz, 2H), 7.56 (d, J = 8.3 Hz, 1H), 7.51 (q, J = 7.7 Hz, 3H), 7.37 (q, J = 7.8, 7.0 Hz, 3H), 7.30 (d, J = 7.9 Hz, 1H), 7.23 (t, J = 7.6 Hz, 1H), 7.19 (t, J = 7.7 Hz, 2H), 7.14–7.10 (m, 3H), 7.07 (t, J = 7.7 Hz, 1H), 6.95–6.92 (m, 1H), 6.66 (d, J = 10.9 Hz, 1H), 6.29 (d, J = 3.4 Hz, 1H); 13C NMR (150 MHz, CDCl3): δ 193.18, 191.94, 137.36, 136.10, 135.91, 135.64, 134.15, 133.72, 133.47, 129.62, 128.87, 128.41, 128.27, 128.06, 127.71, 127.41, 125.52, 125.24, 121.84, 120.45, 119.57, 110.78, 103.35, 59.58, 59.12; HRMS (ESI): m/z [M+H]+ calcd for C30H23BrNO2: 508.0907; found: 508.0908.
2-[(3-Bromophenyl)(1H-indol-1-yl)methyl]-1,3-diphenylpropane-1,3-dione (2n )
White solid (82 mg, 83%); m.p. 204–206 °C; 1H NMR (600 MHz, CDCl3): δ 7.92 (d, J = 7.5 Hz, 2H), 7.71 (d, J = 7.5 Hz, 2H), 7.54 (t, J = 7.4 Hz, 1H), 7.45–7.39 (m, 6H), 7.28 (d, J = 7.7 Hz, 1H), 7.23 (d, J = 7.7 Hz, 3H), 7.17–7.13 (m, 2H), 7.05 (t, J = 7.9 Hz, 1H), 7.01 (t, J = 7.5 Hz, 1H), 6.75 (d, J = 11.0 Hz, 1H), 6.58 (d, J = 11.1 Hz, 1H), 6.36 (d, J = 3.3 Hz, 1H); 13C NMR (150 MHz, CDCl3): δ 192.12, 192.02, 140.67, 136.05, 136.03, 135.72, 133.95, 133.59, 131.30, 130.33, 130.28, 128.94, 128.62, 128.49, 128.40, 128.28, 125.83, 124.87, 122.90, 122.13, 120.77, 119.88, 110.08, 103.38, 60.28, 59.51; HRMS (ESI): m/z [M+H]+ calcd for C30H23BrNO2: 508.0907; found: 508.0906.
2-[(1H-Indol-1-yl)(3-nitrophenyl)methyl]-1,3-diphenylpropane-1,3-dione (2o )
Pale yellow solid (92 mg, 98%); m.p. 95–97 °C; 1H NMR (600 MHz, CDCl3): δ 8.22 (s, 1H), 8.01 (d, J = 7.9 Hz, 1H), 7.94 (d, J = 7.5 Hz, 2H), 7.74 (s, 2H), 7.65 (d, J = 7.2 Hz, 1H), 7.52 (t, J = 7.5 Hz, 1H), 7.43–7.34 (m, 6H), 7.24 (d, J = 6.7 Hz, 3H), 7.17–7.12 (m, 1H), 7.01 (t, J = 7.5 Hz, 1H), 6.88 (d, J = 8.5 Hz, 1H), 6.73–6.67 (m, 1H), 6.38 (d, J = 3.1 Hz, 1H); 13C NMR (150 MHz, CDCl3): δ 192.09, 191.82, 148.30, 140.68, 135.95, 135.79, 135.58, 134.21, 133.81, 133.76, 129.89, 129.04, 128.65, 128.57, 128.51, 128.35, 124.80, 123.16, 122.34, 121.79, 120.96, 120.12, 109.89, 103.90, 60.37, 59.46; HRMS (ESI): m/z [M+H]+ calcd for C30H23N2O4: 475.1652; found: 475.1651.
2-[Furan-2-yl(1H-indol-1-yl)methyl]-1,3-diphenylpropane-1,3-dione (2p )
White solid (71 mg, 86%); m.p. 115–119 °C; 1H NMR (600 MHz, CDCl3): δ 7.99 (d, J = 8.0 Hz, 2H), 7.67 (d, J = 8.3 Hz, 2H), 7.55 (t, J = 7.9 Hz, 2H), 7.44–7.41 (m, 3H), 7.38 (t, J = 7.4 Hz, 1H), 7.27 (d, J = 3.3 Hz, 1H), 7.24 (dd, J = 1.9, 0.9 Hz, 1H), 7.23–7.18 (m, 3H), 7.02 (t, J = 7.4 Hz, 1H), 6.81 (d, J = 10.8 Hz, 1H), 6.71 (d, J = 10.8 Hz, 1H), 6.33 (d, J = 3.1 Hz, 1H), 6.26 (d, J = 3.3 Hz, 1H), 6.21 (dd, J = 3.4, 1.9 Hz, 1H); 13C NMR (150 MHz, CDCl3): δ 192.00, 191.91, 150.92, 142.26, 136.11, 135.82, 135.70, 133.73, 133.48, 128.85, 128.62, 128.41, 128.38, 128.31, 126.09, 121.96, 120.72, 119.72, 110.69, 110.11, 108.77, 103.00, 59.08, 54.19; HRMS (ESI): m/z [M+H]+ calcd for C28H22NO3: 420.1594; found: 420.1595.
2-[(5-Chloro-1H-indol-1-yl)(phenyl)methyl]-1,3-diphenylpropane-1,3-dione (2q )
White solid (92 mg, 99%); m.p. 194–196 °C; 1H NMR (600 MHz, DMSO-d6): δ 8.16 (d, J = 3.2 Hz, 1H), 8.11 (d, J = 7.6 Hz, 2H), 8.07 (d, J = 7.7 Hz, 2H), 7.79 (d, J = 8.8 Hz, 1H), 7.69 (d, J = 7.3 Hz, 2H), 7.56–7.51 (m, 2H), 7.44–7.36 (m, 6H), 7.19 (t, J = 7.7 Hz, 2H), 7.13 (dd, J = 8.8, 2.1 Hz, 1H), 7.09 (t, J = 7.4 Hz, 1H), 6.57 (d, J = 11.1 Hz, 1H), 6.36 (d, J = 3.3 Hz, 1H); 13C NMR (150 MHz, DMSO-d6): δ 192.86, 192.51, 138.54, 135.97, 135.85, 134.85, 134.56, 134.50, 129.35, 129.29, 129.23, 129.18, 128.84, 128.45, 128.23, 127.95, 124.46, 121.82, 119.82, 112.30, 102.40, 60.28, 59.25; HRMS (ESI): m/z [M+H]+ calcd for C30H22ClNO2: 464.1412; found: 464.1413.
2-[(5-Methoxy-1H-indol-1-yl)(phenyl)methyl]-1,3-diphenylpropane-1,3-dione (2r )
Pale yellow solid (84 mg, 92%); m.p. 216–218 °C; 1H NMR (600 MHz, CDCl3): δ 7.89 (d, J = 7.6 Hz, 2H), 7.71 (d, J = 7.6 Hz, 2H), 7.52 (t, J = 7.3 Hz, 1H), 7.42–7.37 (m, 3H), 7.30–7.26 (m, 3H), 7.23 (d, J = 7.9 Hz, 2H), 7.19 (t, J = 7.5 Hz, 2H), 7.16–7.12 (m, 2H), 6.85 (d, J = 2.5 Hz, 1H), 6.78 (dd, J = 9.0, 2.5 Hz, 1H), 6.72 (d, J = 11.1 Hz, 1H), 6.59 (d, J = 11.1 Hz, 1H), 6.24 (d, J = 3.2 Hz, 1H), 3.76 (s, 3H); 13C NMR (150 MHz, CDCl3): δ 192.40, 192.21, 154.06, 138.41, 136.29, 135.92, 133.69, 133.41, 131.42, 128.82, 128.74, 128.60, 128.40, 128.26, 128.05, 127.07, 125.92, 112.09, 110.97, 102.47, 102.43, 60.59, 60.30, 55.77; HRMS (ESI): m/z [M+H]+ calcd for C31H26NO3: 460.1907; found: 460.1907.
2-[(3-Bromophenyl)(5-chloro-1H-indol-1-yl)methyl]-1,3-diphenylpropane-1,3-dione (2s )
White solid (102 mg, 95%); m.p. 145–147 °C; 1H NMR (600 MHz, CDCl3): δ 7.91 (d, J = 8.4 Hz, 2H), 7.72 (d, J = 7.0 Hz, 2H), 7.54 (t, J = 7.3 Hz, 1H), 7.45–7.38 (m, 4H), 7.37 (s, 1H), 7.33 (d, J = 8.8 Hz, 1H), 7.30 (d, J = 7.5 Hz, 1H), 7.27–7.24 (m, 2H), 7.21 (d, J = 7.6 Hz, 1H), 7.18 (d, J = 3.3 Hz, 1H), 7.10 (d, J = 9.1 Hz, 1H), 7.06 (t, J = 7.9 Hz, 1H), 6.70 (d, J = 11.1 Hz, 1H), 6.56 (d, J = 11.2 Hz, 1H), 6.29 (d, J = 3.2 Hz, 1H); 13C NMR (150 MHz, CDCl3): δ 191.99, 191.93, 140.30, 135.92, 135.58, 134.45, 134.07, 133.79, 131.51, 130.40, 130.26, 129.32, 128.99, 128.60, 128.59, 128.28, 126.26, 125.71, 125.60, 123.02, 122.46, 120.17, 111.10, 103.06, 60.10, 59.66; HRMS (ESI): m/z [M+H]+ calcd for C30H22BrClNO2: 542.0517; found: 542.0518.
2-[(5-Methoxy-1H-indol-1-yl)(m-tolyl)methyl]-1,3-diphenylpropane-1,3-dione (2t )
Pale yellow solid (80 mg, 85%); m.p. 167–168 °C; 1H NMR (600 MHz, CDCl3): δ 7.91 (d, J = 7.6 Hz, 2H), 7.73 (d, J = 7.5 Hz, 2H), 7.54–7.49 (m, 1H), 7.43–7.33 (m, 4H), 7.23 (d, J = 7.8 Hz, 2H), 7.17 (d, J = 3.3 Hz, 1H), 7.13–7.06 (m, 3H), 6.96 (d, J = 7.2 Hz, 1H), 6.87 (d, J = 2.4 Hz, 1H), 6.81 (dd, J = 8.9, 2.5 Hz, 1H), 6.71 (d, J = 11.1 Hz, 1H), 6.62 (d, J = 11.1 Hz, 1H), 6.25 (d, J = 3.1 Hz, 1H), 3.77 (s, 3H), 2.19 (s, 3H); 13C NMR (150 MHz, CDCl3): δ 192.57, 192.31, 154.05, 138.50, 138.27, 136.35, 135.95, 133.68, 133.44, 131.46, 128.91, 128.81, 128.78, 128.58, 128.43, 128.28, 128.19, 125.88, 123.86, 112.08, 111.00, 102.45, 102.41, 60.45, 60.30, 55.79, 21.39; HRMS (ESI): m/z [M+H]+ calcd for C32H28NO3: 474.2064; found: 474.2065.
Preparation of 1-[(3,5-diphenyl-1H-pyrazol-4-yl)(phenyl)methyl]-1H-indole (3a )
2-[(1H-Indol-1-yl)(phenyl)methyl]-1,3-diphenylpropane-1,3-dione (
Light yellow solid (38 mg, 90%); m.p. 244–246 °C; 1H NMR (600 MHz, DMSO-d6): δ 13.35 (s, 1H), 7.55 (d, J = 8.1 Hz, 1H), 7.23 (s, 2H), 7.18–7.11 (m, 6H), 7.06 (d, J = 3.3 Hz, 1H), 7.05–6.95 (m, 7H), 6.90 (d, J = 10.9 Hz, 2H), 6.67 (d, J = 7.5 Hz, 2H), 6.43–6.40 (m, 1H); 13C NMR (150 MHz, DMSO-d6): δ 140.22, 135.84, 129.08 (4C), 128.94, 128.66 (5C), 128.47, 128.37, 127.41, 127.39, 127.23, 121.82, 121.14, 119.95, 114.01, 110.56, 101.52, 55.58. HRMS (ESI): m/z [M+H]+ calcd for C30H24N3 426.1965; found: 426.1968.
Supplemental Material
Supporting_Information-revised – Supplemental material for Chemoselective aza-Michael addition of indoles to 2-aroyl-1,3-diarylenones
Supplemental material, Supporting_Information-revised for Chemoselective aza-Michael addition of indoles to 2-aroyl-1,3-diarylenones by Zheng Li, Aizhen Yang, Xiaolong Ma and Zhenrong Liu in Journal of Chemical Research
Footnotes
Declaration of conflicting interests
The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Funding
The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: The authors thank the National Natural Science Foundation of China (21462038) for the financial support of this work.
Supplemental material
Supporting information for 1H NMR and 13C NMR spectra of products
References
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
